Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug-discovery and development challenges.
With around 600 highly educated scientists in six locations in Europe and two the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care.
Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. We blend vast scientific knowledge with inventiveness to make great leaps on your behalf.
Making Molecules Matter. Together.
Company Details
- Employees
- 564
- Founded
- -
- Address
- Kerkenbos 1013, Nijmegen,gelderland 6546bb,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.symeres.com
- Keywords
- medicinal chemistry, parallel chemistry, API development, ADME, ADME-Tox, Process research, Discovery Chemistry.
- HQ
- Nijmegen, Gelderland
Symeres Questions
Symeres's website is http://www.symeres.com
Symeres's LinkedIn profile is https://www.linkedin.com/company/symeresbv
Symeres has
564 employees.
View email and phone details for 564
employees at Symeres.
Symeres's industry is
Biotechnology Research
Symeres's top competitors are
Organix,
Innosyn B.v.,
Ardena,
Oncolines B.v.,
Pivot Park,
Bioconnection,
Byondis,
Admescope,
Exemplify Biopharma, Inc., A Symeres Company,
Synaffix.
Symeres's categories are Biotechnology Research
Symeres's founding year is 1987
